Low-Dose Anticoagulation to Prevent Intracranial Hemorrhage in COVID-19 Patients under Extracorporeal Membrane Oxygenation Support
Am J Respir Crit Care Med
.
2024 Apr 1;209(7):894-895.
doi: 10.1164/rccm.202311-2090LE.
Authors
Pedro David Wendel-Garcia
1
,
Benjamin Seeliger
2
3
4
,
Daniel Hofmaenner
1
,
Christian Bode
5
,
Klaus Stahl
6
,
Sascha David
1
7
Affiliations
1
Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
2
Department of Respiratory Medicine.
3
Biomedical Research in End-Stage and Obstructive Lung Disease Hannover.
4
German Center for Lung Research, Hannover, Germany; and.
5
Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
6
Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology.
7
Department of Nephrology, Hannover Medical School, Hannover, Germany.
PMID:
38306654
PMCID:
PMC10995580
DOI:
10.1164/rccm.202311-2090LE
No abstract available
Publication types
Letter
MeSH terms
Anticoagulants / adverse effects
Blood Coagulation
COVID-19*
Extracorporeal Membrane Oxygenation*
Heparin / pharmacology
Humans
Intracranial Hemorrhages / chemically induced
Retrospective Studies
Substances
Anticoagulants
Heparin